Published in Exp Neurol on October 24, 2007
Sleep drives metabolite clearance from the adult brain. Science (2013) 9.65
Calcium signaling and amyloid toxicity in Alzheimer disease. J Biol Chem (2010) 1.78
Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin (2009) 1.57
Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections. Br J Pharmacol (2012) 1.26
The PI3K-Akt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events. Mol Neurodegener (2009) 1.23
Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease. PLoS One (2009) 1.19
Soluble oligomers of amyloid-β peptide disrupt membrane trafficking of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor contributing to early synapse dysfunction. J Biol Chem (2011) 1.02
In vivo and in vitro validation of reference tissue models for the mGluR(5) ligand [(11)C]ABP688. J Cereb Blood Flow Metab (2010) 1.00
Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease. J Neurochem (2011) 0.99
GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease. Front Cell Neurosci (2014) 0.98
Binding of amyloid beta peptide to beta2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity. FASEB J (2010) 0.96
Action mechanisms of transcranial direct current stimulation in Alzheimer's disease and memory loss. Front Psychiatry (2012) 0.95
Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers. J Biol Chem (2010) 0.94
Significant structural but not physiological changes in cortical neurons of 12-month-old Tg2576 mice. Neurobiol Dis (2008) 0.94
Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology. Mol Neurodegener (2014) 0.89
Insight into glutamate excitotoxicity from synaptic zinc homeostasis. Int J Alzheimers Dis (2010) 0.89
SAMP8 mice have altered hippocampal gene expression in long term potentiation, phosphatidylinositol signaling, and endocytosis pathways. Neurobiol Aging (2013) 0.85
Amyloid beta: multiple mechanisms of toxicity and only some protective effects? Oxid Med Cell Longev (2014) 0.81
Beta-amyloid and glutamate receptors. Exp Neurol (2008) 0.81
Transportation in the Interstitial Space of the Brain Can Be Regulated by Neuronal Excitation. Sci Rep (2015) 0.80
APP and APLP2 interact with the synaptic release machinery and facilitate transmitter release at hippocampal synapses. Elife (2015) 0.80
c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo. Cell Death Dis (2014) 0.80
Guanosine Prevents Anhedonic-Like Behavior and Impairment in Hippocampal Glutamate Transport Following Amyloid-β1-40 Administration in Mice. Mol Neurobiol (2016) 0.80
The effects of sleep loss on capacity and effort. Sleep Sci (2014) 0.79
Dysfunction of NMDA receptors in Alzheimer's disease. Neurol Sci (2016) 0.78
Prolonged Abeta treatment leads to impairment in the ability of primary cortical neurons to maintain K+ and Ca2+ homeostasis. Mol Neurodegener (2010) 0.78
Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease. J Alzheimers Dis (2016) 0.77
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex. Toxicol Sci (2012) 0.77
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease. Curr Neuropharmacol (2016) 0.77
Amyloid-β(25-35) Modulates the Expression of GirK and KCNQ Channel Genes in the Hippocampus. PLoS One (2015) 0.76
Distinct transcriptome expression of the temporal cortex of the primate Microcebus murinus during brain aging versus Alzheimer's disease-like pathology. PLoS One (2010) 0.76
Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies. Neural Plast (2016) 0.76
Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity. PLoS One (2015) 0.76
Cognitive-enhancing effects of hydrolysate of polygalasaponin in SAMP8 mice. J Zhejiang Univ Sci B (2016) 0.75
Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro. BMC Pharmacol (2011) 0.75
Intrahippocampal Administration of Ibotenic Acid Induced Cholinergic Dysfunction via NR2A/NR2B Expression: Implications of Resveratrol against Alzheimer Disease Pathophysiology. Front Mol Neurosci (2016) 0.75
Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders. Neural Plast (2017) 0.75
Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alpha-synuclein. J Neural Transm (Vienna) (2008) 0.75
Role of dimer interface in activation and desensitization in AMPA receptors. Proc Natl Acad Sci U S A (2010) 1.10
Neural cell adhesion molecule-associated polysialic acid regulates synaptic plasticity and learning by restraining the signaling through GluN2B-containing NMDA receptors. J Neurosci (2010) 1.07
Neuroprotective effects of the antiparkinson drug Mucuna pruriens. Phytother Res (2004) 1.05
Versatile effects of sildenafil: recent pharmacological applications. Pharmacol Rep (2007) 1.05
Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function. Synapse (2007) 1.04
Bacopa monniera extract reduces amyloid levels in PSAPP mice. J Alzheimers Dis (2006) 0.99
Posttranslational modifications and receptor-associated proteins in AMPA receptor trafficking and synaptic plasticity. Neurosignals (2007) 0.99
Antioxidant and DNA protecting properties of anti-fatigue herb Trichopus zeylanicus. Phytother Res (2005) 0.97
Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents. Neurobiol Aging (2011) 0.96
AMPA receptor trafficking and synaptic plasticity require SQSTM1/p62. Hippocampus (2009) 0.95
Neural cell adhesion molecule-associated polysialic acid inhibits NR2B-containing N-methyl-D-aspartate receptors and prevents glutamate-induced cell death. J Biol Chem (2006) 0.94
Neural cell adhesion molecule-associated polysialic acid potentiates alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor currents. J Biol Chem (2004) 0.93
Trichopus zeylanicus combats fatigue without amphetamine-mimetic activity. Phytother Res (2006) 0.91
Neurotoxic effects of methamphetamine. Neurochem Res (2009) 0.91
Evaluation of neuroprotective and anti-fatigue effects of sildenafil. Life Sci (2007) 0.89
Methamphetamine-induced neurotoxicity: the road to Parkinson's disease. Pharmacol Rep (2010) 0.89
Aniracetam reversed learning and memory deficits following prenatal ethanol exposure by modulating functions of synaptic AMPA receptors. Neuropsychopharmacology (2007) 0.88
Developmental nicotine exposure induced alterations in behavior and glutamate receptor function in hippocampus. Cell Mol Life Sci (2011) 0.86
Postnatal aniracetam treatment improves prenatal ethanol induced attenuation of AMPA receptor-mediated synaptic transmission. Neurobiol Dis (2007) 0.84
Sulfate- and size-dependent polysaccharide modulation of AMPA receptor properties. J Neurosci Res (2004) 0.83
Selective cholinergic depletion in medial septum leads to impaired long term potentiation and glutamatergic synaptic currents in the hippocampus. PLoS One (2012) 0.83
Single channel recordings from synaptosomal AMPA receptors. Cell Biochem Biophys (2005) 0.82
Paraquat and maneb induced neurotoxicity. Proc West Pharmacol Soc (2007) 0.82
Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmitters. Phytother Res (2004) 0.80
Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers. Life Sci (2007) 0.80
Lysosomal dysfunction produces distinct alterations in synaptic alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid and N-methyl-D-aspartate receptor currents in hippocampus. J Neuropathol Exp Neurol (2007) 0.80
Modulatory effects of dextran sulfate and fucoidan on binding and channel properties of AMPA receptors isolated from rat brain. Synapse (2006) 0.79
Ameliorating effects of preadolescent aniracetam treatment on prenatal ethanol-induced impairment in AMPA receptor activity. Neurobiol Dis (2007) 0.78
Melatonin synergizes with low doses of L-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism. J Pineal Res (2013) 0.78
Antioxidant-mediated reversal of oxidative damage in mouse modeling of complex I inhibition. Drug Dev Res (2015) 0.77
Selective inhibition of phosphodiesterase 5 enhances glutamatergic synaptic plasticity and memory in mice. Synapse (2013) 0.77
Long term alterations in synaptic physiology, expression of β2 nicotinic receptors and ERK1/2 signaling in the hippocampus of rats with prenatal nicotine exposure. Neurobiol Learn Mem (2013) 0.77
Anti-Parkinson botanical Mucuna pruriens prevents levodopa induced plasmid and genomic DNA damage. Phytother Res (2007) 0.77
Investigate the chronic neurotoxic effects of diquat. Neurochem Res (2012) 0.77
Ampakine CX516 ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulation. Exp Neurol (2008) 0.76
Ebselen effects on MPTP-induced neurotoxicity. Brain Res (2006) 0.76
Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content. Life Sci (2008) 0.76
Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity. Neurochem Res (2007) 0.75
Differential effects of dopaminergic neurotoxins on DNA cleavage. Life Sci (2011) 0.75
Assessment of therapeutic potential of amantadine in methamphetamine induced neurotoxicity. Neurochem Res (2013) 0.75